Create Alert
Watchlist
₹1,924.80
-12.50 (0.65%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
1,946.00
Prev. Close
1,937.30
Volume
6,65,614
Total traded value
128 Cr
Upper Circuit
2,131.00
Lower Circuit
1,743.60

Fundamentals

Market Cap₹88,522Cr
ROE19.08%
P/E Ratio(TTM)23.93
EPS(TTM)80.99
P/B Ratio5.15
Dividend Yield0.62%
Industry P/E34.33
Book Value376.64
Debt to Equity0.32
Face Value2
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Lupin

Lupin is a global pharmaceutical leader committed to improving lives by providing a portfolio spanning generics, complex generics, specialty medicines, and biosimilars worldwide. The company's core purpose is to catalyze treatments that transform hope into healing, which guides every decision and action the company undertakes. Demonstrating its market strength, Lupin holds the third position in the United States in terms of total prescriptions dispensed.;
Parent OrganisationLupin Limited
Managing DirectorNA
NSE SymbolLUPIN

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Promoters
46.90%
Foreign Institutions
21.25%
Mutual Funds
19.35%
Retail And Others
6.29%
Other Domestic Institutions
6.21%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Sun Pharmaceutical Industries
NA
(0.00%)
38.26
Cipla
NA
(0.00%)
22.67
Dr Reddy's Laboratories
NA
(0.00%)
18.34
Mankind Pharma
NA
(0.00%)
53.46